Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 494.39% and ...

Wolfe Research initiated coverage of Eli Lilly (LLY) with an Outperform rating and $1,000 price target The company has lost over $100B in ...

LLY has declined 10.6% this month after disappointing third-quarter results. The drug maker has seen strong success in recent ...

Amgen Inc.'s stock dropped over 7% on Tuesday following revelations about bone density loss in early trials of its ...

Investors didn't like what they heard. The big pharma stock initially plunged close to 15% after the market opened on ...

If you looked solely at its stock price, you might get the idea that Eli Lilly (NYSE: LLY) is having a bit of an off quarter.

Eli Lilly ( LLY -1.63%) and Microsoft ( MSFT 1.20%) are two high-flying dividend stocks in the S&P 500 index. Here's why the ...

Eli Lilly's Q3 results show strong sales growth, especially in its Mounjaro and Zepbound franchises, but lowered 2024 outlook ...

However, the stock market largely attributes value to a company based on its ability to generate earnings in the future. Based on Lilly's next twelve months forward P/E ratio, investors are paying ...

While a positive guidance might often drive the stock price higher, a lowered or disappointing guidance is often the reason for a steep decline. After Eli Lilly raised its guidance in the second ...

Eli Lilly (LLY) Stock Price Prediction in 2025 The current Wall Street consensus 1-year price target of Eli Lilly stock is $1030.00, which is 29.00% higher than today’s price of $798.41.